NEW YORK (GenomeWeb News) – CompanionDx and GenomOncology will develop a series of next-generation sequencing-based assays for cancer, the companies said today.

CompanionDx will use GenomOncology's GO Clinical Workbench software to develop a clinical report from the raw sequencing data.

The GO Clinical Workbench analysis is fully traceable and includes a decision support tool for the interpretation of somatic mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.